Long-term treatment of Cushing’s disease with pasireotide: 5-year results from an open-label extension study of a Phase III trial

BACKGROUND: Treating hypercortisolism in patients with Cushing’s disease after failed surgery often requires chronic medication, underlining the need for therapies with favourable long-term efficacy and safety profiles. METHODS: In a randomised, double-blind study, 162 adult patients with persistent...

Descripción completa

Detalles Bibliográficos
Autores principales: Petersenn, S., Salgado, L. R., Schopohl, J., Portocarrero-Ortiz, L., Arnaldi, G., Lacroix, A., Scaroni, C., Ravichandran, S., Kandra, A., Biller, B. M. K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486525/
https://www.ncbi.nlm.nih.gov/pubmed/28597198
http://dx.doi.org/10.1007/s12020-017-1316-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486525/
https://www.ncbi.nlm.nih.gov/pubmed/28597198
http://dx.doi.org/10.1007/s12020-017-1316-3

Ejemplares similares